Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2―Positive Metastatic Breast Cancer: Final Results From the EGF104900 StudyBLACKWELL, Kimberly L; BURSTEIN, Harold J; BASELGA, José et al.Journal of clinical oncology. 2012, Vol 30, Num 21, pp 2585-2592, issn 0732-183X, 8 p.Article

A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal womenCARDOSO, Fatima; BISCHOFF, Joachim; BRAIN, Etienne et al.Cancer treatment reviews. 2013, Vol 39, Num 5, pp 457-465, issn 0305-7372, 9 p.Article

APC promoter hypermethylation is an early event in endometrial tumorigenesisIGNATOV, Atanas; BISCHOFF, Joachim; IGNATOV, Tanja et al.Cancer science. 2010, Vol 101, Num 2, pp 321-327, issn 1347-9032, 7 p.Article

The Role of Intra-cerebrospinal Fluid Treatment and Prophylaxis in Patients With Solid TumorsSOFFIETTI, Riccardo; AKERLEY, Wallace; JENSEN, Randy L et al.Seminars in oncology. 2009, Vol 36, Num 4, issn 0093-7754, S55-S68, SUP2Conference Paper

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III StudyBERGH, Jonas; BONDARENKO, Igor M; CHAN, Arlene et al.Journal of clinical oncology. 2012, Vol 30, Num 9, pp 921-929, issn 0732-183X, 9 p.Article

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancerIGNATOV, Atanas; IGNATOV, Tanja; WEISSENBORN, Christine et al.Breast cancer research and treatment. 2011, Vol 128, Num 2, pp 457-466, issn 0167-6806, 10 p.Article

Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast CancerBLACKWELL, Kimberly L; BURSTEIN, Harold J; BASELGA, Jose et al.Journal of clinical oncology. 2010, Vol 28, Num 7, pp 1124-1130, issn 0732-183X, 7 p.Article

Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR studyMAASS, Nicolai; HARBECK, Nadia; WAGNER, Steffen et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 12, pp 2047-2056, issn 0171-5216, 10 p.Article

Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancerMINCKWITZ, Gunter Von; SCHWEDLER, Kathrin; HARBECK, Nadia et al.European journal of cancer (1990). 2011, Vol 47, Num 15, pp 2273-2281, issn 0959-8049, 9 p.Article

Interval between Port Catheter Flushing Can Be Extended to Four MonthsIGNATOV, Atanas; IGNATOV, Tanja; TARAN, Andrei et al.Gynecologic and obstetric investigation. 2010, Vol 70, Num 2, pp 91-94, issn 0378-7346, 4 p.Article